Korfin Michele Ilene 4

What Happened Michele Ilene Korfin, a director of Organogenesis Holdings Inc. (ORGO), was granted 48,828 restricted stock units (RSUs) on February 18, 2026. The grant was reported on a Form 4 filed February 20, 2026. The filing shows an acquisition at $0.00 because RSUs are awards that convert to shares only upon vesting; these RSUs vest in full on February 15, 2027.

Key Details

• Transaction date: 2026-02-18; Form 4 filed: 2026-02-20 (filed within the 2-business-day window).
• Award: 48,828 RSUs; reported acquisition price: $0.00 (typical for RSU grants).
• Vesting: RSUs vest in full on February 15, 2027 (per filing footnote).
• Shares owned after transaction: not disclosed in the provided Form 4 summary.
• Footnote: The RSUs represent the contingent right to receive one share of Class A common stock per RSU upon vesting (Organogenesis 2018 Equity Incentive Plan).

Context RSU grants are a form of compensation that do not immediately transfer tradable shares — value is realized only if and when the units vest and shares are delivered. The economic value to the insider at grant depends on Organogenesis’s stock price at vesting; taxes are generally due when RSUs vest or shares are delivered. This is a routine insider compensation event rather than an open-market purchase or sale.